Assenagon Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86M Buy
103,955
+36,802
+55% +$1.12M 0.01% 707
2026
Q1
$2.27M Sell
67,153
-43,287
-39% -$1.23M ﹤0.01% 759
2025
Q4
$3.01M Buy
110,440
+43,287
+64% +$1.52M ﹤0.01% 766
2025
Q3
$2.7M Buy
+67,153
New +$2.53M ﹤0.01% 770
2024
Q4
Sell
-7,409
Closed -$329K 1315
2024
Q3
$329K Sell
7,409
-127,571
-95% -$5.79M ﹤0.01% 1288
2024
Q2
$5.82M Sell
134,980
-319,821
-70% -$11.5M 0.01% 587
2024
Q1
$13.3M Buy
454,801
+404,297
+801% +$10.8M 0.04% 364
2023
Q4
$1.12M Buy
50,504
+41,768
+478% +$936K ﹤0.01% 1070
2023
Q3
$216K Hold
8,736
﹤0.01% 1333
2023
Q2
$247K Sell
8,736
-89,847
-91% -$2.24M ﹤0.01% 1257
2023
Q1
$2.26M Sell
98,583
-13,905
-12% -$369K 0.01% 792
2022
Q4
$3.16M Buy
112,488
+18,839
+20% +$531K 0.01% 660
2022
Q3
$2.65M Sell
93,649
-15,653
-14% -$420K 0.01% 632
2022
Q2
$2.42M Buy
+109,302
New +$2.47M 0.01% 760
2020
Q3
Sell
-51,412
Closed -$2.75M 1104
2020
Q2
$2.75M Buy
+51,412
New +$2.38M 0.02% 497

Other funds holding AGIO